Iida S, Nakamura Y, Fujii H, Nishimura J, Tsugawa M, Gomi M, Fukata J, Tarui S, Moriwaki K, Kitani T
Second Department of Internal Medicine, Osaka University Medical School, Japan.
J Clin Endocrinol Metab. 1990 Mar;70(3):729-37. doi: 10.1210/jcem-70-3-729.
One patient is reported who has the manifestations of Cushing's syndrome in spite of persistent hypocortisolemia. His serum levels of cortisol and free cortisol were below normal, and 24-h urinary excretion of 17-hydroxycorticosteroids and cortisol were decreased. There was a rapid and substantial increase in serum cortisol in response to synthetic ACTH-(1-24). Plasma levels of ACTH were marginally increased by successive administration of CRH and vasopressin, which were followed by substantial increases in serum cortisol. Glucocorticoid activity of the patient's serum, as measured by a RRA was low. There were no responses of urinary 17-hydroxycorticosteroids after metyrapone treatment. These laboratory examinations ruled out any known clinical conditions resulting in hypocortisolemia. The clinical condition could also be explained by cortisol hyperreactivity of the patient's cells. In vitro hyperreactivity to glucocorticoids was demonstrated in cultured skin fibroblasts whose aromatase activity was increased 1.5- to 1.8-fold above that of normal cells, and [3H]thymidine incorporation was inhibited more effectively by the addition of cortisol or dexamethasone. The mechanism by which the patient is hyperreactive to glucocorticoids remains unexplained.
报告了1例尽管存在持续性皮质醇血症,但仍有库欣综合征表现的患者。其血清皮质醇和游离皮质醇水平低于正常,24小时尿17 - 羟皮质类固醇和皮质醇排泄量减少。对合成促肾上腺皮质激素(1 - 24)的反应中,血清皮质醇迅速且大幅增加。连续给予促肾上腺皮质激素释放激素(CRH)和血管加压素后,促肾上腺皮质激素(ACTH)血浆水平略有升高,随后血清皮质醇大幅增加。通过放射受体分析法(RRA)测定,患者血清的糖皮质激素活性较低。甲吡酮治疗后尿17 - 羟皮质类固醇无反应。这些实验室检查排除了任何已知导致皮质醇血症的临床情况。该临床状况也可以用患者细胞对皮质醇的高反应性来解释。在培养的皮肤成纤维细胞中证实了对糖皮质激素的体外高反应性,其芳香化酶活性比正常细胞增加了1.5至1.8倍,添加皮质醇或地塞米松能更有效地抑制[3H]胸腺嘧啶核苷掺入。患者对糖皮质激素高反应的机制仍未得到解释。